Report Detail
Global Antipsychotics Market Insights, Forecast to 2025
- RnM3442324 |
- 22 May, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
The global Antipsychotics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antipsychotics market based on company, product type, end user and key regions.
This report studies the global market size of Antipsychotics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antipsychotics in these regions.
This research report categorizes the global Antipsychotics market by top players/brands, region, type and end user. This report also studies the global Antipsychotics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Pfizer
Eli Lilly & Co
Bristol-Myers Squibb
AstraZeneca
Glaxo SmithKline
Allergan
Market size by Product
First Generation
Second Generation
Third Generation
Market size by End User
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antipsychotics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antipsychotics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antipsychotics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antipsychotics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antipsychotics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antipsychotics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Antipsychotics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antipsychotics Market Size Growth Rate by Product
- 1.4.2 First Generation
- 1.4.3 Second Generation
- 1.4.4 Third Generation
- 1.5 Market by End User
- 1.5.1 Global Antipsychotics Market Size Growth Rate by End User
- 1.5.2 Schizophrenia
- 1.5.3 Bipolar Disorder
- 1.5.4 Unipolar Depression
- 1.5.5 Dementia
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antipsychotics Market Size
- 2.1.1 Global Antipsychotics Revenue 2014-2025
- 2.1.2 Global Antipsychotics Sales 2014-2025
- 2.2 Antipsychotics Growth Rate by Regions
- 2.2.1 Global Antipsychotics Sales by Regions
- 2.2.2 Global Antipsychotics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antipsychotics Sales by Manufacturers
- 3.1.1 Antipsychotics Sales by Manufacturers
- 3.1.2 Antipsychotics Sales Market Share by Manufacturers
- 3.1.3 Global Antipsychotics Market Concentration Ratio (CR5 and HHI)
- 3.2 Antipsychotics Revenue by Manufacturers
- 3.2.1 Antipsychotics Revenue by Manufacturers (2014-2019)
- 3.2.2 Antipsychotics Revenue Share by Manufacturers (2014-2019)
- 3.3 Antipsychotics Price by Manufacturers
- 3.4 Antipsychotics Manufacturing Base Distribution, Product Types
- 3.4.1 Antipsychotics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antipsychotics Product Type
- 3.4.3 Date of International Manufacturers Enter into Antipsychotics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Antipsychotics Sales by Product
- 4.2 Global Antipsychotics Revenue by Product
- 4.3 Antipsychotics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Antipsychotics Breakdown Data by End User
6 North America
- 6.1 North America Antipsychotics by Countries
- 6.1.1 North America Antipsychotics Sales by Countries
- 6.1.2 North America Antipsychotics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antipsychotics by Product
- 6.3 North America Antipsychotics by End User
7 Europe
- 7.1 Europe Antipsychotics by Countries
- 7.1.1 Europe Antipsychotics Sales by Countries
- 7.1.2 Europe Antipsychotics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antipsychotics by Product
- 7.3 Europe Antipsychotics by End User
8 Asia Pacific
- 8.1 Asia Pacific Antipsychotics by Countries
- 8.1.1 Asia Pacific Antipsychotics Sales by Countries
- 8.1.2 Asia Pacific Antipsychotics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antipsychotics by Product
- 8.3 Asia Pacific Antipsychotics by End User
9 Central & South America
- 9.1 Central & South America Antipsychotics by Countries
- 9.1.1 Central & South America Antipsychotics Sales by Countries
- 9.1.2 Central & South America Antipsychotics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Antipsychotics by Product
- 9.3 Central & South America Antipsychotics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Antipsychotics by Countries
- 10.1.1 Middle East and Africa Antipsychotics Sales by Countries
- 10.1.2 Middle East and Africa Antipsychotics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antipsychotics by Product
- 10.3 Middle East and Africa Antipsychotics by End User
11 Company Profiles
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Johnson & Johnson Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Johnson & Johnson Antipsychotics Products Offered
- 11.1.5 Johnson & Johnson Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Antipsychotics Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Eli Lilly & Co
- 11.3.1 Eli Lilly & Co Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Eli Lilly & Co Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Eli Lilly & Co Antipsychotics Products Offered
- 11.3.5 Eli Lilly & Co Recent Development
- 11.4 Bristol-Myers Squibb
- 11.4.1 Bristol-Myers Squibb Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Bristol-Myers Squibb Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Bristol-Myers Squibb Antipsychotics Products Offered
- 11.4.5 Bristol-Myers Squibb Recent Development
- 11.5 AstraZeneca
- 11.5.1 AstraZeneca Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AstraZeneca Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AstraZeneca Antipsychotics Products Offered
- 11.5.5 AstraZeneca Recent Development
- 11.6 Glaxo SmithKline
- 11.6.1 Glaxo SmithKline Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Glaxo SmithKline Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Glaxo SmithKline Antipsychotics Products Offered
- 11.6.5 Glaxo SmithKline Recent Development
- 11.7 Allergan
- 11.7.1 Allergan Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Allergan Antipsychotics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Allergan Antipsychotics Products Offered
- 11.7.5 Allergan Recent Development
12 Future Forecast
- 12.1 Antipsychotics Market Forecast by Regions
- 12.1.1 Global Antipsychotics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antipsychotics Revenue Forecast by Regions 2019-2025
- 12.2 Antipsychotics Market Forecast by Product
- 12.2.1 Global Antipsychotics Sales Forecast by Product 2019-2025
- 12.2.2 Global Antipsychotics Revenue Forecast by Product 2019-2025
- 12.3 Antipsychotics Market Forecast by End User
- 12.4 North America Antipsychotics Forecast
- 12.5 Europe Antipsychotics Forecast
- 12.6 Asia Pacific Antipsychotics Forecast
- 12.7 Central & South America Antipsychotics Forecast
- 12.8 Middle East and Africa Antipsychotics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antipsychotics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Antipsychotics. Industry analysis & Market Report on Antipsychotics is a syndicated market report, published as Global Antipsychotics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Antipsychotics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
